MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled,Safety, Immunogenicity, and Dose-escalation Study in Adults With and Without Latent Tuberculosis Infection in South Africa
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 29 Dec 2017
At a glance
- Drugs MTBVAC (Primary) ; BCG vaccine
- Indications Tuberculosis
- Focus Adverse reactions
- 11 Dec 2017 Planned initiation date to 8 Jan 2018.
- 07 Sep 2017 Planned End Date changed from 1 Sep 2018 to 1 Mar 2019.
- 07 Sep 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2018.